In addition, stratified analyses revealed that EGF A61G polymorphism was associated with the increased risk of CRC amongst the females, old subjects (age ≥60 years), smokers, and drinkers, indicating that the interactions between those factors and EGF A61G polymorphism contributed to increased risk for CRC patients. This evidence concerns the gene EGF and colorectal carcinoma.